Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Bruce A Keyt

3PUBLICATIONS

23CO-AUTHORS

Molecular, biological, and multi-scale communicationsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Nov 27, 2025

Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.

Zhiqiang Ku, Xuping Xie, Paul R Hinton

|May 22, 2025

IGM-7354, an Immunocytokine with IL15 Fused to an Anti-PD-L1 IgM, Induces NK and CD8+ T cell-Mediated Cytotoxicity of PD-L1-Positive Tumor Cells.

Mélanie Desbois, Thierry Giffon, Poonam Yakkundi

|Jun 03, 2021

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.

Zhiqiang Ku, Xuping Xie, Paul R Hinton

Pageof 1

Frequent Collaborators

2 joint publications

Zhiqiang Ku

2 joint publications

Xuping Xie

2 joint publications

Paul R Hinton

2 joint publications

Vineet D Menachery

2 joint publications

Ningyan Zhang

2 joint publications

Stephen F Carroll

2 joint publications

Pei-Yong Shi

2 joint publications

Zhiqiang An

1 joint publications

Mélanie Desbois

1 joint publications

Thierry Giffon

Frequent Collaborators

2 joint publications

Zhiqiang Ku

2 joint publications

Xuping Xie

2 joint publications

Paul R Hinton

2 joint publications

Vineet D Menachery

Top Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on : Sep 19, 2016

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

See more related videos

Top Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on : Sep 19, 2016

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

See more related videos